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The biosynthesis of materials using medicinal plants can be a low-
cost and eco-friendly approach due to their extraordinary prop-
erties. Herein, we reported a facile synthesis of Fe3O4 nanoparticles
using Malva sylvestris. The surface morphology, functional groups,
and elemental analysis were done to characterize the synthesized
nanoparticles. The cytotoxicity performance of the synthesized
nanoparticles was analyzed by exposing nanoparticles to MCF-7
and Hep-G2 cancer cell lines through MTT colorimetric assay and
the IC50 value was defined as 100 mg/mL and 200 mg/mL, respec-
tively. The antibacterial performance of synthesized nanoparticles
against four different bacterial strains including Staphylococcusmental Health Engineering, Faculty of Health and Nutrition, Bushehr Uni-
Nanotechnology, School of Advanced Medical Sciences and Technologies,
Hashemi), b.ramavandi@bpums.ac.ir (B. Ramavandi).
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as an antibacterial, antiseptic, and chemo-preventive agent in cancer1. Data
The experimental data on cytotoxic and antibacterial activity of synthesized Fe3O4 nanoparticles
using Malva sylvestris are reported in this dataset. To validate the successful synthesis of Fe3O4
nanoparticles using Malva sylvestris, Fourier transform infrared spectroscopy (FTIR) was applied to
determine the functional groups in the nanoparticles (Fig. 1a). The X-ray powder diffraction (XRD)
analysis is depicted in Fig. 1b. SEM images and EDX analysis of Fe3O4 nanoparticles and Fe3O4/Malva
sylvestris nanoparticles are presented in Fig. 2.
The cytotoxic effects of synthesized Fe3O4 nanoparticles using Malva sylvestris against Hep-G2 and
MCF-7 cell lines have demonstrated in Fig. 3. The inhibitory effect of synthesized Fe3O4 nanoparticles
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Fig. 1. (a) FTIR and (b) XRD results for the Fe3O4 and Fe3O4/Malva sylvestris nanoparticles.
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(see Fig. 4). The performance of nanoparticles against selected microorganisms is presented in Table 1.
The raw data source for this dataset is available in the Supplementary section.
2. Experimental design, materials, and methods
2.1. Preparation of Fe3O4/Malva sylvestris nanoparticles
All of the materials utilized in this investigation like Ferrous(ІІ) Sulfate Heptahydrate (FeSO4.7H2O),
Iron(III) Chloride Six hydrate (FeCl3.6H2O) and Ammonia solution were purchased from Merck Co.
(Germany). First, 4.75 g FeCl3.6H2O, 3.89 g FeSO4.7H2O, and 320mL deionizedwater were poured into a
round-bottom flask and stirred for 1 h while the temperature was set to 80 C [1,2]. Then, 0.5 g Malva
sylvestris was ultrasonically mixed in 120 mL of deionized water for 30 min and then poured into the
previous suspension. The obtained suspension was stirred under 80 C for about 2 h and after that 40
mL NH3 was gradually added to the suspension [3]. After filtration, the suspensionwas washed and the
pH scale was set on 7 and finally dried in an oven at 100 C for 2 h.
2.2. Characterization of nanoparticles
The synthesized nanoparticles were characterized using Fourier-transform infrared spectroscopy
(FTIR, Tensor ІІ FT-IR spectroscopy Bruker, Germany) in the region of 400e4000 cm1, X-ray diffraction
(XRD, Panalytical model X'Pert Pro), scanning electron microscope (SEM, Tescan model Mira III), and
EDX (Tescan model S Max detector Mira III).
Fig. 2. FESEM images and EDAX analysis of (a,b) Fe3O4 nanoparticles and (c,d) Fe3O4/Malva sylvestris nanoparticles.
S.M. Mousavi et al. / Data in brief 28 (2020) 10492942.3. MTT assay
The cytotoxicity of the synthesized nanoparticles was evaluated on Hep-G2 and MCF-7 cell lines
usingMTTcolorimetric assay. In this method, hydrogen peroxidewas considered as the positive control
and culture medium was the negative control. Briefly, a certain number of Hep-G2 and MCF-7 cells
(10*103) were placed in each well of a sterile 96-well microplate and incubated in a humidified at-
mosphere of 5% CO2, 95% air at 37 C to reach about 75e90% confluence. Then,100 mL of the synthesized
nanoparticles in a wide range of concentrations was replaced with previous media. Afterward, 25 mL of
the MTT 3-(4,5 Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium stock solution (with 4 mg/mL con-
centration) was transferred into each well and incubated for 4 h in standard condition. The mito-
chondrial performance of viable cells led to formation of purple formazan crystals, where for dissolving
these crystals we applied 100 mL dimethyl sulfoxide (DMSO). In the final step, the absorption of solution
was recorded at 570 nm wavelength using a microplate reader (Model 50, Bio-Rad Corp, Hercules,
California, USA).2.4. Minimum inhibitory concentrations (MICs) assay
In MICs test, all of the procedures were carried out according to the standards of the Clinical and
Laboratory Standards Institute (CLSI) for assessing the antibacterial susceptibility of the synthesized
nanoparticles [4]. Briefly, 2-fold serial dilutions of the testing compounds (at a descending concen-
tration from 1000mg/ml to 7.8 mg/mL) and control groups were providedwith Brain heart infusion (BHI)
in 96-well microplates. Afterward, the microbial concentration was adapted to match the turbidity
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Fig. 3. Effect of nanoparticles on cell viability of MTT assay for all tested concentrations on Hep-G2 and MCF-7 cells after 24 h in
comparison with control (untreated cell). Each bar represents the mean ± SD (standard deviation) of three independent tests.
S.M. Mousavi et al. / Data in brief 28 (2020) 104929 5standard of 0.5 McFarland (OD600: 0.1e0.2) in a way that the concentration of the compounds was
1000 mg/mL in the first wells. The plates were incubated for 24 h at 37 C. Later the optical density was
measured at 600 nm by a microplate reader (BioTek, Power Wave XS2). This procedure was done in
triplicate.2.5. Minimum Bactericidal Concentrations (MBCs) assay
All the selected microorganisms were cultured overnight in BHI, and then stocks with the con-
centration of 105e106 CFU/mL were prepared for each one. The total of 90 mL of serially diluted con-
centrations of compounds (from 1000 mg/mL to 7.8 mg/mL) was added to a 96-well micro-plate
consisting of 90 mg/mL BHI, then 10 mg/ml of bacteria were added to each cell. Micro-plates were
incubated for 24 h at 37 C. Then,10 mL of each bacterial suspensionwas added to a newly prepared BHI
and incubated for another 24 hours at 37 C to exam bactericidal performance of each compound The
lowest concentration of compounds that leads no growth of bacteria was regarded as minimum
bactericidal concentration (MBC). This procedure was also repeated three times.
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Fig. 4. Effect of nanoparticles on the viability percentages of Corynebacterium, Klebsiella pneumoniae, Staphylococcus aureus, Pseu-
domonas aeruginosa in tested concentrations (each bar represents the mean ± SD (standard deviation) of three independent tests).
Table 1
Performance of nanoparticles against selected microorganisms.
Microorganisms Fe3O4 nanoparticles
(mg/mL)
Fe3O4/Malva sylvestris
nanoparticles (mg/mL)
MIC MBC MIC MBC
Staphylococcus aureus 250 250 125 >125
Corynebacterium 500 1000 62.5 125
Pseudomonas aeruginosa 250 500 125 >125
Klebsiella pneumoniae 500 500 125 >125
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